330350 Stock Chart & Stats
₩7400.00
-₩500.00(-6.33%)
―
--
Day’s Range― - ―
52-Week Range₩5,910.00 - ₩11,950.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)768.30K
Market Cap
₩97.66B
Enterprise Value₩82.96K
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)12.3
Beta0.40
Next Earnings
Nov 18, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)149.12
Shares Outstanding13,199,680
10 Day Avg. Volume1,951,033
30 Day Avg. Volume768,302
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
330350 FAQ
What was WITHUS PHARMACEUTICAL Co., Ltd.’s price range in the past 12 months?
WITHUS PHARMACEUTICAL Co., Ltd. lowest stock price was ₩5910.00 and its highest was ₩11950.00 in the past 12 months.
What is WITHUS PHARMACEUTICAL Co., Ltd.’s market cap?
WITHUS PHARMACEUTICAL Co., Ltd.’s market cap is ₩97.66B.
When is WITHUS PHARMACEUTICAL Co., Ltd.’s upcoming earnings report date?
WITHUS PHARMACEUTICAL Co., Ltd.’s upcoming earnings report date is Nov 18, 2026 which is in 66 days.
How were WITHUS PHARMACEUTICAL Co., Ltd.’s earnings last quarter?
WITHUS PHARMACEUTICAL Co., Ltd. released its earnings results on Aug 14, 2026. The company reported ₩149.115 earnings per share for the quarter.
Is WITHUS PHARMACEUTICAL Co., Ltd. overvalued?
According to Wall Street analysts WITHUS PHARMACEUTICAL Co., Ltd.’s price is currently Undervalued.
Does WITHUS PHARMACEUTICAL Co., Ltd. pay dividends?
WITHUS PHARMACEUTICAL Co., Ltd. does not currently pay dividends.
What is WITHUS PHARMACEUTICAL Co., Ltd.’s EPS estimate?
WITHUS PHARMACEUTICAL Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does WITHUS PHARMACEUTICAL Co., Ltd. have?
WITHUS PHARMACEUTICAL Co., Ltd. has 13,199,680 shares outstanding.
What happened to WITHUS PHARMACEUTICAL Co., Ltd.’s price movement after its last earnings report?
WITHUS PHARMACEUTICAL Co., Ltd. reported an EPS of ₩149.115 in its last earnings report. Following the earnings report the stock price went down -0.132%.
Which hedge fund is a major shareholder of WITHUS PHARMACEUTICAL Co., Ltd.?
Currently, no hedge funds are holding shares in KR:330350
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Technical Analysis
Sam-A Pharm. Co., Ltd.
―
KOREA PHARMA Co., Ltd.
―
OPTUS Pharmaceutical Co. Ltd.
―
Icure Pharmaceutical Incorporation
―
DongKook Life Science Co., Ltd.
―